Literature DB >> 32343467

Acceptance and use of a smartphone application in cirrhosis.

Jeremy Louissaint1, Anna S Lok1, Brett E Fortune2, Elliot B Tapper1,3.   

Abstract

BACKGROUND AND AIMS: The development of cirrhosis-related smartphone applications for remote monitoring is increasing. Whether patients with cirrhosis will welcome such new technology, however, is uncertain.
METHODS: We prospectively enrolled patients with cirrhosis (N = 102) to determine predictors of acceptance and utilization of a smartphone application for cirrhosis management using a 12-item Technology Acceptance Model (TAM) survey. Patients were then shown the EncephalApp© and evaluated for their willingness to download and use the application.
RESULTS: Patients had a median age of 61.3 years and 63.7% had a history of hepatic decompensation. Intention to use the hypothetical application was associated with perceived usefulness (β: 0.4, 95% CI: 0.3-0.5) and the presence of a caregiver (β: 1.1, 95% CI: 0.2-2.0). Of the eligible participants, 71% agreed to download the EncephalApp© and the decision was influenced by computer anxiety, behavioural intent, caregiver presence and disease state factors. Actual usage was 32% and not associated with baseline characteristics or the technology acceptance model.
CONCLUSIONS: Patient acceptance of smartphone applications for the management of cirrhosis is high and related to their attitudes towards technology and the presence of a caregiver. However, usage was low. Future research must employ behavioural interventions to optimize uptake and utilization of remote monitoring technology.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cirrhosis; smartphone application; technology acceptance model; telehealth

Mesh:

Year:  2020        PMID: 32343467     DOI: 10.1111/liv.14494

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  7 in total

Review 1.  Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy.

Authors:  Jeremy Louissaint; Sasha Deutsch-Link; Elliot B Tapper
Journal:  Clin Gastroenterol Hepatol       Date:  2022-08       Impact factor: 13.576

2.  A Care Coordination Intervention Improves Symptoms But Not Charges in High-Risk Patients With Inflammatory Bowel Disease.

Authors:  Jeffrey A Berinstein; Shirley A Cohen-Mekelburg; Gillian M Greenberg; Daniel Wray; Sameer K Berry; Sameer D Saini; A Mark Fendrick; Megan A Adams; Akbar K Waljee; Peter D R Higgins
Journal:  Clin Gastroenterol Hepatol       Date:  2021-08-28       Impact factor: 13.576

Review 3.  The digital transformation of hepatology: The patient is logged in.

Authors:  Tiffany Wu; Douglas A Simonetto; John D Halamka; Vijay H Shah
Journal:  Hepatology       Date:  2022-01-31       Impact factor: 17.298

4.  Strategies to Improve Video Visit Use in Persons With Liver Disease.

Authors:  Jeremy Louissaint; Jeffrey T Gibbs; Anna S Lok; Elliot B Tapper
Journal:  Gastroenterology       Date:  2021-06-29       Impact factor: 33.883

Review 5.  Sociotechnical Factors Affecting Patients' Adoption of Mobile Health Tools: Systematic Literature Review and Narrative Synthesis.

Authors:  Christine Jacob; Emre Sezgin; Antonio Sanchez-Vazquez; Chris Ivory
Journal:  JMIR Mhealth Uhealth       Date:  2022-05-05       Impact factor: 4.947

Review 6.  Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action.

Authors:  Sumeet K Asrani; Jessica Mellinger; Juan P Arab; Vijay H Shah
Journal:  Hepatology       Date:  2021-05       Impact factor: 17.298

Review 7.  Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.

Authors:  Catherine T Frenette; Cynthia Levy; Sammy Saab
Journal:  Dig Dis Sci       Date:  2021-06-24       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.